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Abstract 
The appearance of COVID-19 has set tasks for healthcare professionals related to rapid diagnosis 
and provision of medical care to patients. The diagnosis of COVID-19 infection is based on the 
complex application of clinical, radiological and laboratory research methods[1].Radiation research 
methods used to diagnose patients with suspected COVID-19 and viral pneumonia of another nature 
include: radiography, computed tomography and ultrasound examination of the lungs. Radiation 
imaging data allow us to suspect lung damage of viral etiology (including COVID-19), influence the 
management of a particular patient, the treatment of complications or the formulation of an 
alternative diagnosis with a high probability of lung damage of viral etiology. 
 
Detection of antibodies to SARS-CoV-2 is carried out using immunochemical methods. Class A 
(IgA) antibodies begin to form and are available for detection from about 2 days from the onset of 
the disease, reach a peak after 2 weeks and persist for a long time. Class M antibodies (IgM) begin to 
be detected approximately on the 7th day from the beginning of infection, reach a peak after a week 
and can persist for 2 months or more. From about the 3rd week or earlier, antibodies of class G (IgG) 
to SARS-CoV-2 are detected. A feature of the humoral response to infection is a small time interval 
between the appearance of IgM and IgG antibodies, and sometimes their simultaneous formation [8-
10]. 
Studies have demonstrated the high efficiency of computed tomography (CT) of the chest organs in 
the diagnosis of pneumonia caused by SARS-CoV-2, and only in some studies this position was 
questioned[3,11,18]. However, most publications are devoted, in fact, to CT-semiotics of lung tissue 
damage, assessment of the prevalence of the process and the dynamics of its development. At the 
same time, the issues of the diagnostic significance of CT at the early stage of COVID-19, 
recognition and correct interpretation of lung damage in the first 5 days of the onset of symptoms of 
the disease remain insufficiently studied [15,17]. Based on the results of the analysis of data obtained 
during the study in patients with suspected SARS-CoV-2-pneumonia, it was demonstrated that CT is 
a highly sensitive method for diagnosing pathological changes in lung tissue. 
According to the results of the conducted complex of clinical examination, the question of the type of 
medical care and the amount of additional examination is decided. The diagnosis is established on 
the basis of a clinical examination, epidemiological history and laboratory results, as well as 
radiation methods. 
The purpose of the study. Study of the semiotics of pathological changes in the lungs according to 
CT data in the clinical symptoms of COVID-19. 
Materials and methods of research. The study was based on the results of a comprehensive 
clinical, X-ray examination of the chest, computed tomography and PCR test, as well as ultrasound 
examination of the lungs in 112 patients.The patients were monitored from May 2020 to May 2021 
in the X-ray room of the Bukhara Regional Infectious Diseases Hospital.All patients underwent 
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computed tomography of the lungs using ToshibaAquilion 32 and GE revolution EVO 128 scanners. 
Tomography was performed in a routine mode at a voltage of 120 kV on an X-ray tube. The program 
loaded a series of CT images of the chest with a slice thickness of 1 mm.  
When studying the period before the appearance of clinical symptoms of pneumonia caused by 
COVID-19 in patients, we obtained the following results: in 19 (16.9%) patients - 1-7 days, in 72 
patients-7-21 days (64.3%) and in 21 (18.7%) patients - 21 - 30 days. In patients under 40 years of 
age, the symptoms of COVID 19 pneumonia often ranged from 1 to 7 days, while in most patients of 
the older age group, the duration ranged from 7 to 21 days. 
COVID-19 is usually manifested by fever in 91 patients (81.3%), dry cough or with a small amount 
of sputum (66.0 and 61.6%) and shortness of breath (62.0%), other respiratory tract symptoms 
(runny nose, pain when swallowing 72.3%), other signs of damage are possible (diarrhea and 
symptoms of gastrointestinal tract damage-20.5%). Based on the data, we can say that the most 
common triad of symptoms was considered fever, dry cough and symptoms of gastrointestinal tract 
damage. 
When determining the results of the PCR test, they were positive in 72 patients, i.e. 64.3%, and 
negative results were in 39 cases, i.e. 34.8%, in doubtful cases-in 1 (0.9%) patient. 
Risk factors for severe course include old age, diabetes mellitus, coronary heart disease, arterial 
hypertension and chronic obstructive pulmonary disease. 
Based on the survey data of 112 patients with varying degrees of clinical and radiological picture and 
studied foreign publications on the current issue, approaches to the diagnosis of COVID-19 were 
determined. 
In our study, the“frosted glass " symptom prevailed. This sign is represented by a small compaction 
of the parenchyma without its volumetric change, with partial preservation of pneumatization, due to 
which bronchial and vascular structures are observed. Numerous seals of the lung tissue according to 
the "frosted glass" type are mainly of a rounded shape, of various lengths with / without 
consolidation (Fig.1). 
 
Fig. 1. Patient M., 46 years old. CT of the lungs, "pulmonary window", axial and coronary planes. 
Areas of "frosted glass" with uneven and clear contours are defined along the periphery. 
Most often, the "frosted glass" was bilateral – in 87 (79.0%) patients, only subpleural lesions were 
detected in 23 (20.9%), but there were patients in whom CT examination only revealed areas of 
“frosted glass” of both peripheral 15 (13.6%) and central localization-9 (8.2%). Among the typical 
manifestations of the “frosted glass” symptom, either drain foci were detected-in 74 (67.3%) cases, 
or rounded foci - in 36 (32.7%) cases. 
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In 16 (14.5%) cases, there was a lesion of the dorsal parts, in 94 (85.4%) – a chaotic lesion of 
different segments, both peripheral and central localization (Fig. 2). 
 
Fig. 3. Computed tomograms of the lungs. The patient is 49 years old. The dorsal parts of the lungs 
are more affected. The PCR test is negative. 
 
 
Fig. 4. Computed tomograms of the lungs. The patient is 55 years old. The dorsal parts of the lungs 
are more affected. 
 
Fig. 5. Computed tomograms of the lungs. The patient is 45 years old. The dorsal parts of the lungs 
are more affected. 
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The second most common symptom was the consolidation of lung tissue, it was observed in 54 
patients (49.1%). Consolidation on tomograms is visualized as a homogeneous compaction of the 
pulmonary parenchyma, which hides the walls of blood vessels and the walls of the respiratory tract  
(Fig.5). 
 
The different prevalence and semiotics of COVID-19-associated pneumonia indicate a different 
reaction of the body to infection. It is emphasized that it is necessary to comply with certain 
methodological requirements when performing MSCT in patients with pneumonia caused by SARS-
CoV-2. The effect of an air bronchogram against the background of consolidations in our patients 
has always been preserved. That is, the bronchi and bronchioles in COVID-19 are passable and are 
almost not involved in the process in the absence of bacterial infection. 
It should be borne in mind that CT signs of COVID-19-associated pneumonia may lag behind or 
outstrip the clinical symptoms of the disease in terms of time of manifestation. 
Conclusions.  
1. Typical radiological manifestations of viral pneumonia (COVID-19) include – 
 a symptom of the "frosted glass" type, numerous compressions of the lung tissue of mainly 
rounded shape, of various lengths with / without consolidation, peripheral, multilobar 
localization; - the lesion is more often bilateral in nature; 
 thickening of the interlobular interstitial according to the type of "cobblestone pavement"; 
 areas of consolidation, perilobular seals; - a symptom of an air bronchogram, traction 
bronchiectasis; 
 pleural effusion, hydrothorax (bilateral, predominant on the left). 
2. The percentage of damage is estimated separately for each lung. The degree of changes is 
determined by the lung with the greatest lesion. 
3. Computed tomography of the chest organs is recommended for use: in outpatient conditions in 
patients with suspected COVID-19 (including after radiography of the OGC); CT imaging is 
indicated for medical sorting of patients with suspected COVID-19 who have clinical signs of 
moderate severity and its high probability before receiving test results. CT imaging is not indicated 
for patients with suspected COVID-19 and moderate clinical signs, without risk factors for disease 
progression. 
Given the high contagiousness of this infection and the constant need for radiation research methods, 
it is necessary to protect medical workers as much as possible. In patients with a mild or moderate 
course, with positive dynamics, complete lung recovery can be observed. In patients with a severe 
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course, negative dynamics may be observed with the progression of the disease: as an increase in the 
prevalence of interstitial changes, the transformation of" frosted glass " into gross reticular changes 
or into massive areas of consolidation of lung tissue. CT of the chest organs, taking into account its 
high sensitivity, helps in making a diagnosis, monitoring the course of the disease, playing an 
important role in making clinical decisions in the treatment of COVID-19. 
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